Featuring posts written by the DoseSpot e-Prescribing Integration Team!

Apple’s iPad Marks Healthcare Territory

Posted: October 31st, 2014 | Author: | Filed under: In the News, Telehealth | Tags: , , , , , , , , , , | No Comments »

Among the various verticals that Apple’s iPad now occupies, recent discussions suggests that the healthcare space may be benefiting the most. The topic of iPad use in healthcare surfaced at VentureBeat’s HealthBeat 2014 conference Tuesday, where Drchrono’s Daniel Kivatinos, Direct Dermatology’s Dr. Angela Walker and Welltok’s Michelle Snyder discussed the use of mobile technology like the iPad and Google Glass in today’s medical realm.

According to Kivatinos, Walker and Snyder, the iPad has had a huge impact on medical practices because it can be used for physician-oriented tasks previously restricted to desktop computers. After the official iPad launch in 2010, many doctors soon gravitated towards the device and incorporated its use into everyday medical practices.

Dr. Walker of Direct Dermatology added that she didn’t fully adopt the iPad in her dermatology practice until the iPad mini came out—she liked how it fit nicely in her white coat’s pocket. Welltok’s Snyder then pointed out that Drchrono was the first to create an EHR app for Google Glass. Some questions still remain around the use of Google Glass in the healthcare vertical, as privacy issues are teased out. The benefits, however, seem to be plentiful at the moment.

Kivatinos described Google Glass’ efficacy, in that quickly pressing Glass’ “record” button to capture a portion of a patient visit could be wildly helpful for both doctor and patient. Walker added that Google Glass might also be useful in patient education: “[surgery is] a discipline where doctors’ hands might be busy a lot and Glass can be helpful…In any setting where your hands are tied, it can be useful.” As discussions surrounding iPads and Google Glass in the medical field continue to multiply, one overall conclusion is very clear: mobile devices are changing the way healthcare professionals run their practices.

Did you miss out on HealthBeat 2014? Catch up on some interesting chats and happenings here!

SOURCE: VentureBeat

About DoseSpot 
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.


“Map My Body:” Google’s Newest Health Endeavor Spans the Genome

Posted: July 31st, 2014 | Author: | Filed under: Basics, In the News | Tags: , , , , , , , | No Comments »

 

SOURCE: Vanity Fair

We’re surrounded by hundreds of health terms on a daily basis, but what does it truly mean to be “healthy”? Google X, the research branch of Google, may soon have an answer for us. As first reported by the Wall Street Journal and later confirmed by Google, Google X has embarked on a bio-medical research project called ‘Baseline Study’ that will aggregate anonymous genetic and molecular information. The Study will initially test 175 people to solidify data collection methods—with thousands more to come— to create an accurate picture of the healthy human.

The 175-person pilot group will go through extensive medical testing, including blood and saliva analyses. Once completed, the Baseline Study team will review all samples with researchers at Duke University and Stanford University, the anticipated sites for the eventual, large-scale study.

In response to privacy concerns, Google told the Wall Street Journal that any data collected for Baseline will be anonymous, used only for medical purposes, and will not be shared with insurance companies. Baseline’s aim is to act as a reference database for the chemistry of a well-machined, healthy body—and, subsequently, identify abnormalities much earlier. With the birth of Baseline, the hope is that the medical community will move towards prevention rather than treatment in response to disease.

Sources: The Next Web and  Business Insider

For more information on Google’s groundbreaking health plans, check out this article by TIME Magazine: http://time.com/3045429/google-baseline-study-human-health/

About DoseSpot

DoseSpot is a Surescripts™ certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.


The Health Tracking Race: Who Will Win?

Posted: June 30th, 2014 | Author: | Filed under: In the News | Tags: , , , , , , , , , , , , , | No Comments »

Ready to get fit from the comfort of your own smartphone or tablet? Recent developments in the tech sphere likely have you covered. Over the past few weeks, three major players in the digital health industry–Google, Apple and Samsung–have unveiled newly polished, fitness-ready consumer health apps for public viewing. The initial verdicts on Google Fit, Samsung’s Gear Fit, and Apple’s iOS 8 Health app are officially out. Take a look below to see what consumers are saying:

 

Google Fit 

Google Product Manager Ellie Powers describes the new Google Fit platform at the 2014 Google I/O, Google’s annual developers’ conference held in San Francisco.

 

Basics: fitness and health tracking platform for Android smart devices. Google Fit will aggregate users’ fitness data in one place, and sync data from popular wearable devices created by Nike, Adidas, and more.

Pros: comprehensive data analysis in one location, complete picture of users’ fitness and better tracking of fitness goals, single set of APIs for all health products.

Cons: too similar to already-existing data aggregation platforms, failure to address how medical professionals might access this data, potential compatibility issues.

 

Gear Fit by Samsung

 

 

Basics: a wearable activity-tracking wristband with a heart rate monitor, pedometer, and flexible display screen. Well-suited for basic activities such as running, walking, cycling, and hiking.

Pros: excellent display resolution, customizable screen features (backgrounds and clock face), changeable watch bands, compatible with at least 17 Samsung smartphones and tablets, notable ‘smartwatch’ features (phone call, text message, and email alerts).

Cons: error-prone and “bare bone” activity trackers, faulty mileage calculations, very low battery life (vs. JawBone and FitBit models), poor accessibility (requires bulky “charging cradle”).

 

Apple iOS 8 Health

     

 

Basics: iPhone app that allows users to collect biometric information (i.e. heart rate, blood pressure, etc.) and automatically send it to doctors or hospitals via the Medical ID feature.

Pros: comprehensive set of activity trackers (fitness, nutrition, sleep patterns, blood glucose levels, cholesterol levels, etc.), customizable and seamless user interface.

Cons: performance concerns with exchange of medical data (physicians bombarded with low-priority data and patient compliance issues).

Sources: TechCrunch, Apple, and The Verge. 

 

Need more convincing? Engage your critical consumer eye with these helpful articles:

Gear Fit by Samsung: http://www.forbes.com/sites/ewanspence/2014/06/22/samsung-gear-fit-review-a-combined-fitness-band-and-stylish-smartwatch-for-your-galaxy-smartphones/

Google Fit: http://news360.com/article/243439279

Apple iOS 8 Health: http://9to5mac.com/2014/06/02/a-closer-look-at-ios-8s-health-app-video/

 

About DoseSpot

DoseSpot is a Surescripts™ certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.